Cargando…
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
PURPOSE: Curcumin has shown to exert a positive impact on human glucose metabolism, even if its bioavailability is usually very low. The present study aimed to explore the effect of phosphatidylserine- and piperine-containing curcumin phytosomes on a large number of metabolic parameters related to i...
Autores principales: | Cicero, Arrigo F. G., Sahebkar, Amirhossein, Fogacci, Federica, Bove, Marilisa, Giovannini, Marina, Borghi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058573/ https://www.ncbi.nlm.nih.gov/pubmed/30796508 http://dx.doi.org/10.1007/s00394-019-01916-7 |
Ejemplares similares
-
Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
por: Cicero, Arrigo F. G., et al.
Publicado: (2017) -
Noninvasive instrumental evaluation of coenzyme Q(10)
phytosome on endothelial reactivity in healthy nonsmoking young volunteers: A double‐blind, randomized, placebo‐controlled crossover clinical trial
por: Cicero, Arrigo F. G., et al.
Publicado: (2022) -
Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product
por: Cicero, Arrigo Francesco Giuseppe, et al.
Publicado: (2017) -
Effect of Dietary Supplementation with Eufortyn(®) Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study
por: Fogacci, Federica, et al.
Publicado: (2022) -
Effect of combined lipid-lowering and antioxidant nutraceutical on plasma lipids, endothelial function, and estimated cardiovascular disease risk in moderately hypercholesterolemic patients: a double-blind, placebo-controlled randomized clinical trial
por: Cicero, Arrigo F.G., et al.
Publicado: (2021)